Question 1

What are the differences between NovoSeven® and FEIBA in treating joint bleeds?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of NovoSeven® in Haemophilia - Joint Bleeds clinical trial (NCT00108797). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this trial affect my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of NovoSeven® in Haemophilia - Joint Bleeds clinical trial (NCT00108797). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with NovoSeven®?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of NovoSeven® in Haemophilia - Joint Bleeds clinical trial (NCT00108797). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatments if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of NovoSeven® in Haemophilia - Joint Bleeds clinical trial (NCT00108797). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of NovoSeven® in Haemophilia - Joint Bleeds clinical trial (NCT00108797). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any long-term effects I should consider before participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of NovoSeven® in Haemophilia - Joint Bleeds clinical trial (NCT00108797). Contact the study team or your healthcare provider for specific answers.

What this study is about